Department of Obstetrics.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021 Jun 25;50(3):313-319. doi: 10.3724/zdxbyxb-2020-0013.
To explore the correlation of mid-term oral glucose tolerance test (OGTT) and maternal weight gain with adverse pregnancy outcomes in women with gestational diabetes mellitus (GDM). A total of 2611 pregnant women with GDM who were examined and delivered in Women's Hospital, Zhejiang University School of Medicine from July 1st 2017 to 30th June 2018 were enrolled in this study. According to the number of abnormal items of mid-term OGTT results or maternal gestational weight gain (GWG), patients were classified. The incidence of adverse perinatal outcomes in each group and its relation with OGTT results and GWG were analyzed. The incidence of gestational hypertension, premature delivery, macrosomia and large for gestational age infant (LGA) in three abnormal items GDM patients were significantly higher than those in one or two abnormal items GDM patients (all <0.017). The incidence of gestational hypertension and premature delivery in two abnormal items GDM patients were higher than those in one abnormal item GDM patients (all <0.017). The incidence of gestational hypertension and macrosomia in excessive GWG patients were significantly higher than those in inadequate and appropriate GWG patients (all <0.017), and the incidence of LGA were higher than that in inadequate GWG patients (all <0.017). The incidence of premature delivery and low birth weight infants in appropriate GWG patients were significantly lower than those in inadequate and excessive GWG patients, and the incidence of small for gestational age infant (SGA) were significantly lower than that in inadequate GWG patients (all <0.017). In one abnormal item GDM patients, inadequate GWG was a risk factor for premature delivery and SGA (=1.66, 95%: 1.10-2.52; =2.20, 95%: 1.07-4.53), and protective factor for LGA (=0.40, 95%: 0.27-0.59). And excessive GWG was a risk factor for gestational hypertension, premature delivery and low birth weight infants (=2.15, 95%: 1.35-3.41; =1.80, 95%: 1.20-2.72; =2.18, 95%: 1.10-4.30).In two abnormal items GDM patients, inadequate GWG was a protective factor for macrosomia and LGA (=0.24, 95%: 0.09-0.67; =0.54, 95%: 0.34-0.86), while excessive GWG was risk factor for premature delivery (=1.98, 95%: 1.23-3.18).In three abnormal items GDM patients, there was no significant relationship between GWG and adverse pregnancy outcomes. For GDM women with one or two items of elevated blood glucose in OGTT, reasonable weight management during pregnancy can reduce the occurrence of adverse pregnancy outcomes. For those with three items of elevated blood glucose in OGTT, more strict blood glucose monitoring and active intervention measures should be taken in addition to weight management during pregnancy.
探讨中期口服葡萄糖耐量试验(OGTT)和孕妇体重增加与妊娠期糖尿病(GDM)患者不良妊娠结局的相关性。选取 2017 年 7 月 1 日至 2018 年 6 月 30 日在浙江大学医学院附属妇产科医院检查和分娩的 2611 例 GDM 孕妇,根据中期 OGTT 结果或孕妇妊娠期体重增加(GWG)异常项目的数量将患者进行分类。分析各组不良围生期结局的发生率及其与 OGTT 结果和 GWG 的关系。3 项异常 GDM 患者的妊娠期高血压、早产、巨大儿和大于胎龄儿(LGA)的发生率明显高于 1 项或 2 项异常 GDM 患者(均<0.017)。2 项异常 GDM 患者的妊娠期高血压和早产发生率高于 1 项异常 GDM 患者(均<0.017)。GWG 过多患者的妊娠期高血压和巨大儿发生率明显高于 GWG 不足和适当患者(均<0.017),LGA 发生率高于 GWG 不足患者(均<0.017)。GWG 适当患者的早产和低出生体重儿发生率明显低于 GWG 不足和过多患者,小于胎龄儿(SGA)发生率明显低于 GWG 不足患者(均<0.017)。在 1 项异常 GDM 患者中,GWG 不足是早产和 SGA 的危险因素(=1.66,95%:1.10-2.52;=2.20,95%:1.07-4.53),是 LGA 的保护因素(=0.40,95%:0.27-0.59)。GWG 过多是妊娠期高血压、早产和低出生体重儿的危险因素(=2.15,95%:1.35-3.41;=1.80,95%:1.20-2.72;=2.18,95%:1.10-4.30)。在 2 项异常 GDM 患者中,GWG 不足是巨大儿和 LGA 的保护因素(=0.24,95%:0.09-0.67;=0.54,95%:0.34-0.86),而 GWG 过多是早产的危险因素(=1.98,95%:1.23-3.18)。在 3 项异常 GDM 患者中,GWG 与不良妊娠结局之间无显著关系。对于 OGTT 有 1 项或 2 项血糖升高的 GDM 妇女,孕期合理的体重管理可降低不良妊娠结局的发生。对于 OGTT 有 3 项血糖升高的患者,除了孕期体重管理外,还应采取更严格的血糖监测和积极的干预措施。